Clinical Trials on CNS in Finland
Total 124 results
-
Orion Corporation, Orion PharmaCompleted
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
Turku University HospitalActive, not recruiting
-
Turku University HospitalRecruiting
-
Turku University HospitalEnrolling by invitationMultiple SclerosisFinland
-
Turku University HospitalCompletedMultiple SclerosisFinland
-
University of TurkuUnknownColecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)Multiple SclerosisFinland
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Kuopio University HospitalCompletedRelapse-remitting Multiple SclerosisFinland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
Finnish MS SocietySeinajoki Central Hospital; Social Insurance Institution, Finland; Tampere University...Completed
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
GuerbetCompletedBlood Brain Barrier Defect | CNS LesionKorea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
-
SanofiCompletedMultiple SclerosisUnited States, France, Canada, Germany, Spain, Finland, Norway
-
US Department of Veterans AffairsTerminated
-
US Department of Veterans AffairsCompletedMultiple SclerosisUnited States
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
US Department of Veterans AffairsTerminated
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
US Department of Veterans AffairsCompletedMS (Multiple Sclerosis)United States
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
SanofiCompletedMultiple SclerosisUkraine, Russian Federation, Estonia, Czech Republic, Denmark, Finland, France, Turkey, United Kingdom, United States, Portugal, Austria, Canada, Chile, Germany, Italy, Netherlands, Norway, Poland, Sweden, Switzerland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...CompletedMultiple SclerosisUnited Kingdom, Germany, Finland, Israel, Spain, Canada, France, Australia, Czechia, Austria, Sweden, Poland, Hungary, Italy
-
UCB PharmaBiogenTerminatedMultiple SclerosisUnited States, France, Germany, Spain, Canada, Netherlands, Belgium, Hungary, Sweden, United Kingdom, Finland
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple SclerosisUnited States
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
BiogenCompletedMultiple SclerosisUnited States
-
SanofiCompletedMultiple SclerosisFinland, Belgium, Spain, Chile, Norway, Italy, United States, Austria, Canada, France, Germany, Greece, Sweden, United Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisUnited Kingdom, Germany, Israel, Finland, Canada, Australia, Czechia, Spain, France, Italy, Austria, Hungary, Poland, Sweden
-
BayerCompletedMultiple SclerosisSpain, Belgium, Czechia, Italy, United Kingdom, Hungary, Germany, Switzerland, Austria, France, Poland, Canada, Sweden, Finland, Israel, Denmark, Norway, Portugal
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
BiogenCompletedMultiple SclerosisUnited States, Finland, Italy, United Kingdom, Bulgaria, Serbia, Russian Federation, Lithuania, Poland, Czech Republic, Netherlands
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Turkey, Estonia, Germany, Latvia, Poland, Romania, Argentina, Israel, Portugal, Greece, Czech Republic, Slovakia, Serbia, Austria, Finland, Saudi Arabia, Belgium, Canada, Lebanon and more
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States